Related Experiment Video

Updated: Sep 27, 2025

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.0K

Anti-Jagged-1 immunotherapy in cancer

Joanna Pancewicz1, Wieslawa Niklinska1, Andrzej Eljaszewicz2

  • 1Department of Histology and Embryology, Medical University of Bialystok, Bialystok, Poland.

Advances in Medical Sciences
|April 14, 2022
PubMed

Insights

Jagged-1 (JAG1) is crucial in cancer biology. This review explores JAG1-targeted immunotherapies, highlighting their potential in cancer treatment strategies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Notch signaling is a conserved pathway regulating cell proliferation, differentiation, and apoptosis.
  • Dysregulation of Notch signaling components is implicated in various cancers and diseases.
  • Jagged-1 (JAG1) is a Notch ligand with significant ties to tumor biology.

Purpose of the Study:

  • To review the significance of Jagged-1 (JAG1) in cancer biology.
  • To focus on current reports of JAG1-directed cancer treatment, particularly immunotherapy.

Main Methods:

  • Literature review of current reports on JAG1 and cancer therapy.
  • Emphasis on immunotherapeutic approaches targeting JAG1.

Main Results:

  • Jagged-1 (JAG1) plays a key role in tumor biology.
  • Monoclonal antibodies targeting JAG1 show therapeutic potential in cancer treatment.

Conclusions:

  • JAG1-directed cancer treatment, especially immunotherapy, is a promising area of research.
  • Targeting JAG1 offers a potential strategy for novel cancer therapies.
Keywords:
CancerImmunotherapyJAG1 therapyNotch signaling

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.6K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
689
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
533
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K